Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Lower fair value on ASX best idea

Shares are still undervalued despite drop in profit margins.
stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,184.2027.30-0.30%
CAC 408,330.9716.23-0.19%
DAX 4025,286.24134.42-0.53%
Dow JONES (US)49,149.6342.36-0.09%
FTSE 10010,184.3547.000.46%
HKSE26,907.6892.13-0.34%
NASDAQ23,471.75238.13-1.00%
Nikkei 22554,110.50230.73-0.42%
NZX 50 Index13,659.7997.92-0.71%
S&P 5006,926.6037.14-0.53%
S&P/ASX 2008,861.7019.30-0.22%
SSE Composite Index4,109.8616.23-0.39%

Market Movers